Repligen (RGEN) Common Equity (2010 - 2026)

Repligen (RGEN) has 17 years of Common Equity data on file, last reported at $2.1 billion in Q1 2026.

• Common Equity for Q1 2026 came in at $2.1 billion, up 6.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 billion (up 6.04% YoY), and the FY2025 annual result was $2.1 billion, up 6.76% from the prior year.
• Common Equity held at $2.1 billion in Q1 2026 per RGEN's latest filing, from $2.1 billion in the prior quarter.
• Over five years, Common Equity peaked at $2.1 billion in Q4 2025 and troughed at $1.8 billion in Q1 2022.
• A 5-year average of $2.0 billion and a median of $2.0 billion in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2024: Common Equity advanced 13.51% in 2022, then increased 0.4% in 2024.
• A 5-year view of Common Equity shows it stood at $1.9 billion in 2022, then climbed by 2.83% to $2.0 billion in 2023, then increased by 0.4% to $2.0 billion in 2024, then advanced by 6.76% to $2.1 billion in 2025, then slipped by 0.03% to $2.1 billion in 2026.
• Business Quant data shows RGEN's Common Equity at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.